HR, J., J, L., SP, H., N, S., A, C., DJ, S., . . . SY, C. (2024). Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Experimental & molecular medicine, 56(2), 355. https://doi.org/10.1038/s12276-024-01159-5
Chicago Style (17th ed.) CitationHR, Jung, et al. "Targeting the M6A RNA Methyltransferase METTL3 Attenuates the Development of Kidney Fibrosis." Experimental & Molecular Medicine 56, no. 2 (2024): 355. https://doi.org/10.1038/s12276-024-01159-5.
MLA (9th ed.) CitationHR, Jung, et al. "Targeting the M6A RNA Methyltransferase METTL3 Attenuates the Development of Kidney Fibrosis." Experimental & Molecular Medicine, vol. 56, no. 2, 2024, p. 355, https://doi.org/10.1038/s12276-024-01159-5.
Warning: These citations may not always be 100% accurate.